Pain. Acute Pain
Conditions
Interventions
Intervention 1: Drugs:
1-Teramadol:
Dose: 100 mg
Number of using: Once
Factory name: Alborz Darou
Manufacturing Country's Name: Iran
Location prescribed: Intravenous
Administration time: After
Treatment - Drugs
Drugs:
1-Teramadol:
Dose: 100 mg
Number of using: Once
Factory name: Alborz Darou
Manufacturing Country's Name: Iran
Location prescribed: Intravenous
Administration time: After end of su
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - The patient's satisfaction – Age between 18 and 30 years old - ASA class I & II Exclusion criteria: - The lack of patient's satisfaction to spinal anesthesia - History of hypnotics or narcotics throughout 24 hours before the surgery - History of drug abuse, or alcohol dependency - Contraindications of Spinal Anesthesia( Patient refusal ; Infection at the site of planned needle puncture ; Elevated intracranial pressure and Bleeding diathesis)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 2,4,8,12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid Consumption. Timepoint: 24 hours after surgery. Method of measurement: Milligram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShaghayegh Mousavian
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed